Med-Cannabis Pharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
-
8.10
-
-
-
Cost of Goods Sold (COGS) incl. D&A
-
0.20
-
-
-
Gross Income
-
8.00
-
-
-
SG&A Expense
58,902.00
65.20
299.10
561.10
98.80
EBIT
58,902.00
57.20
299.10
561.10
98.80
Unusual Expense
-
-
-
51.40
-
Non Operating Income/Expense
-
-
-
52.60
-
Interest Expense
4.10
4.30
13.50
73.30
302.00
Pretax Income
58,906.10
61.50
312.50
738.50
400.80
Consolidated Net Income
58,906.10
61.50
312.50
738.50
400.80
Net Income
58,906.10
61.50
312.50
738.50
400.80
Net Income After Extraordinaries
58,906.10
61.50
312.50
738.50
400.80
Net Income Available to Common
58,906.10
61.50
312.50
738.50
400.80
EPS (Basic)
0.40
0.00
0.00
0.01
0.01
Basic Shares Outstanding
147,653.70
303,369.90
141,659.20
50,217.90
50,347.00
EPS (Diluted)
0.40
0.00
0.00
0.01
0.01
Diluted Shares Outstanding
147,653.70
303,369.90
141,659.20
50,217.90
50,347.00
EBITDA
58,902.00
57.20
299.10
561.10
98.80
About Med-Cannabis Pharma
View Profile
